Clinical Trials Browser

Interventional × HER2-positive × Trastuzumab × Clear all

NCT05218148 2022-04-06

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Phase 2 Unknown

GastrointestinalOther solid neoplasm

HER2-positive